Quest Diagnostics Inc
DGX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| !%@ | LOCK|@!J$q | LOCK|Vw<>v! |
Quest Diagnostics Has Carved Out a Narrow Moat on Its Attractive Cost Structure
Business Strategy and Outlook
Quest Diagnostics is a leading provider of independent diagnostic testing in the US thanks to its network of roughly 2,400 patient service centers across the country. Quest's scale-driven cost advantage allows the firm to benefit from several secular trends, including the proliferation of diagnostic tests and greater clinical reliance on personalized therapies. Additionally, Quest is enjoying a reprieve from Medicare-related pricing pressure as regulators tinker with the method for setting lab test reimbursement rates.
